CUREVAC NVLong
Trading Idea - #CUREVAC (hope for the mutants)
THE BIG LONG! Vaccine for the Covid-Mutants! :-)
ENTRY: 44.20 EUR
TARGET: 90.00 EUR (104 % profit)
STOP: 32.40 EUR
- This is only an interim analysis result of the CUREVAC Covid vaccince!!
- Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues.
- The vaccine candidate is in the final stage of clinical development.
- CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis.
- But continue the current study until the final analysis.
ENTRY: 44.20 EUR
TARGET: 90.00 EUR (104 % profit)
STOP: 32.40 EUR
- This is only an interim analysis result of the CUREVAC Covid vaccince!!
- Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues.
- The vaccine candidate is in the final stage of clinical development.
- CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis.
- But continue the current study until the final analysis.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.